Key Finding
Acupuncture combined with usual care reduced IBS symptom severity by 75.6 points more than sham acupuncture in refractory IBS patients, with sustained benefits through follow-up.
Irritable bowel syndrome (IBS) can be challenging to treat, especially when conventional treatments don't provide adequate relief. Researchers conducted a large study involving 170 patients with refractory IBS—meaning their symptoms persisted despite standard medical care—to determine whether acupuncture could offer additional benefits. Half the patients received real acupuncture while the other half received sham (placebo) acupuncture, with neither group knowing which treatment they were getting. Both groups continued their usual medical care and attended 12 treatment sessions over 4 weeks.
The results were encouraging. Patients who received real acupuncture experienced significantly greater improvement in their IBS symptoms compared to those receiving sham acupuncture. Using a standardized symptom severity scale, the acupuncture group showed an average improvement of 140 points, while the sham group improved by only 64 points—a meaningful difference of about 76 points. These improvements were measured across various IBS symptoms including abdominal pain, bowel dysfunction, and quality of life impacts. Importantly, the benefits persisted during the 4-week follow-up period after treatment ended, and no serious side effects were reported.
For patients struggling with IBS that hasn't responded well to conventional treatments, this study suggests that acupuncture may be a valuable addition to their treatment plan. The research indicates that acupuncture provides real therapeutic effects beyond placebo, offering hope for symptom relief when other approaches have fallen short. If you're considering acupuncture for IBS, seek treatment from a licensed acupuncturist with experience in digestive disorders.
This multicenter randomized sham-controlled trial (n=170) evaluated acupuncture efficacy for refractory IBS patients continuing conventional treatment. Participants received 12 sessions of real or sham acupuncture over 4 weeks (3 sessions/week). The primary outcome measured change in IBS-Symptom Severity Scale (IBS-SSS) from baseline to week 4. Results demonstrated significant superiority of real acupuncture: IBS-SSS decreased 140.0 points (95% CI: 126.0-153.9) in the acupuncture group versus 64.4 points (95% CI: 50.4-78.3) in controls, yielding a between-group difference of 75.6 points (95% CI: 55.8-95.4). Treatment effects persisted through 4-week follow-up with no serious adverse events reported. The study provides robust evidence for acupuncture as an effective adjunctive therapy for treatment-resistant IBS, demonstrating clinically meaningful improvements beyond placebo effects. These findings support incorporating acupuncture into multimodal management strategies for refractory IBS cases.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.